← Back to news

Markets

Oil Rises On Israel-Iran Conflict Uncertainty

Y

Israel-Iran Conflict Unlikely to Lift Gold Price in Long Term

Y

Zoom Video Communications Stock Has More Than Doubled the Performance of the S&P 500 Over the Last Year. Is It the Beginning of a Long-Term Comeback?

Y

Oil Fluctuates as Israel-Iran Conflict Fuels Market Volatility

Y

Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock

Y

History Says the Stock Market Is About to Soar: 2 Brilliant AI Stocks to Buy Now

Y

Global Markets Mostly Fall; Oil Price Rises on Fresh Iran, Israel Attacks

Y

Where Will C3.ai Stock Be in 3 Years?

Y

Kiatnakin Phatra and Goldman Sachs collaboration expands Thai investment

Y

AIB Group Returns to Private Ownership as Irish State Completes Exit

Y

Tesla Stock Drops. Why Wall Street Is Split on Musk’s Robotaxi Launch.

Y

Blackstone Secured Lending: I Stopped Buying One Of My Top BDCs (Rating Downgrade)

S

Dollar Climbs as Oil Prices Rise on Middle East Tensions

Y

Oil Market Well Supplied But Geopolitical Risks Bring Uncertainty, IEA Says

Y

World oil demand to keep growing this decade despite 2027 China peak, IEA says

Y

Anne Wojcicki's bid to buy back 23andMe may not end legal fight over DNA customer data

Y

Anne Wojcicki's bid to buy back 23andMe may not end a legal fight over DNA customer data

Y

Stock Futures Drop, Oil Rises as Israel-Iran Cease-Fire Hopes Fade

Y

Oil Prices Rise as Israel-Iran Conflict Fuels Market Volatility

Y

Ashtead Posts Softer Profit; Says U.S. Listing On Track

Y

LandBridge: Buy Recommendation For This High-Quality Investment Choice

S

Volvo, Daimler Truck Launch Vehicle Software Joint Venture

Y

Pinterest Earns Membership In 95-Plus Composite Rating Club

Y

More of Us Are Putting in Extra Hours After the Workday

Y

Fabrinet Seems To Be Working Its Way Back Up To Its Recent Record High

Y

ASOS Replaces Finance Chief Amid Turnaround Plan

Y

Häagen-Dazs, Starbucks Mull Overhauls in China to Fend Off Powerful Local Rivals

Y

Legal & General Flags Good Start to 2025, Confirms Targets

Y

Corn Prices Are Sliding. A Seasonal Slump Could Start Tuesday.

Y

'Deep pockets' could help Abu Dhabi win regulatory approval for Santos bid, analysts say

Y

GSK Licenses Shigella Vaccine to Bharat Biotech

Y

Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating

Y

Cardinal Health (CAH) Affirms Long-Term Growth Raises Outlook

Y

Tenet Healthcare Corp (THC) on the Spot over Medicare Fraud Allegations

Y

Morgan Stanley Hikes McKesson (MCK) Price Target on Earnings Growth Prospects

Y

IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners

Y

Ascendis Pharma (ASND) Rated as a Hold at Cannacord Genuity on Growth Hormone Prospects

Y

Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety Concern

Y

Cigna (CI) Unveils AI-Powered Tools to Enhance Healthcare Delivery

Y

Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating

Y

AbbVie (ABBV) Pipeline Bolstered as FDA Approves Mavyret Label Expansion for Hepatitis C

Y

UBS Affirms Neutral Rating on Baxter International (BAX)

Y

AbbVie, ADARx Pharmaceuticals Partner to Develop Next-Gen siRNA Therapeutics

Y

IAG: Earnings Jet To New Heights, Yet All-Time Highs Stay In The Hangar - Sell The Cycle-Peak

S

Tipping Points - How Will Markets Respond?

S

CoreWeave: Three Realistic Scenarios, Pick Yours

S

Nutrien: Not Attractive Enough To Justify Buying Yet

S

Berkshire Hathaway: Buffett's Out, Billions In Doubt

S

Conflict concerns weigh on indexes, bolster oil and US debt

Y

SoftBank raises $4.8 billion from T-Mobile share sale, term sheet shows

Y